“…Like HSD17B3, mutations in SRD5A2 can lead to a variety of phenotypes [Akcay et al, 2014], and the role of SRD5A2 in 46,XY DSD has been studied for almost 40 years. Indeed, various mutations in this gene have been linked with an increased risk of hypospadias [Silver and Russell, 1999; Wang et al, 2004; Samtani et al, 2011; Wang R et al, 2013; Carmichael et al, 2014] and one hypospadias-associated variant, the SRD5A2 V89L polymorphism, is less active in vitro [Thai et al, 2005]. Differences in the activity of SRD5A2 variants may explain why some are associated with hypospadias [Silver and Russell, 1999], while others are reported to reduce the risk of both mild and severe hypospadias [Thai et al, 2005] (tables 1, 2).…”